Cardiac Hypertrophy: The Good, the Bad, and the Ugly
Top Cited Papers
- 1 March 2003
- journal article
- review article
- Published by Annual Reviews in Annual Review of Physiology
- Vol. 65 (1), 45-79
- https://doi.org/10.1146/annurev.physiol.65.092101.142243
Abstract
▪ Abstract Cardiac hypertrophy is the heart's response to a variety of extrinsic and intrinsic stimuli that impose increased biomechanical stress. While hypertrophy can eventually normalize wall tension, it is associated with an unfavorable outcome and threatens affected patients with sudden death or progression to overt heart failure. Accumulating evidence from studies in human patients and animal models suggests that in most instances hypertrophy is not a compensatory response to the change in mechanical load, but rather is a maladaptive process. Accordingly, modulation of myocardial growth without adversely affecting contractile function is increasingly recognized as a potentially auspicious approach in the prevention and treatment of heart failure. In this review, we summarize recent insights into hypertrophic signaling and consider several novel antihypertrophic strategies. The same thing that makes you live can kill you in the end. —Neil YoungKeywords
This publication has 225 references indexed in Scilit:
- NFAT SignalingCell, 2002
- Src and Multiple MAP Kinase Activation in Cardiac Hypertrophy and Congestive Heart Failure Under Chronic Pressure-overload: Comparison with Acute Mechanical StretchJournal of Molecular and Cellular Cardiology, 2001
- The Akt-Glycogen Synthase Kinase 3β Pathway Regulates Transcription of Atrial Natriuretic Factor Induced by β-Adrenergic Receptor Stimulation in Cardiac MyocytesPublished by Elsevier ,2000
- The Nuclear δB Isoform of Ca2+/Calmodulin-dependent Protein Kinase II Regulates Atrial Natriuretic Factor Gene Expression in Ventricular MyocytesJournal of Biological Chemistry, 1997
- Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammationNature, 1997
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart FailureNew England Journal of Medicine, 1996
- Dissociation of p44 and p42 Mitogen-activated Protein Kinase Activation from Receptor-induced Hypertrophy in Neonatal Rat Ventricular MyocytesPublished by Elsevier ,1996
- Ras Activity Is Required for Phenylephrine-Induced Activation of Mitogen-Activated Protein Kinase in Cardiac Muscle CellsBiochemical and Biophysical Research Communications, 1994
- Prognostic Implications of Echocardiographically Determined Left Ventricular Mass in the Framingham Heart StudyNew England Journal of Medicine, 1990
- Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human HeartsNew England Journal of Medicine, 1982